OCTALFA is a family-owned, Lyon-based investment company specializing in life sciences. It is part of the initiative OCTALFA, which encompasses the Dominique & Tom Alberici-OCTALFA Foundation dedicated to disabled and cancer patients, OCTALFA (life sciences) and OTONNALE (cleantech/greentech).
For more information, visit: http://initiative-octalfa.com
SHAM is a French mutual insurance company based in Lyon that specializes in medical malpractice liability. SHAM, which is one of the French leaders in its sector, has a portfolio of assets of 1.4 billion Euros invested in a variety of mediums. Since 2007, it has also been investing in young innovative businesses in the health industry.
For more information, visit: www.sham.fr
Rhône Alpes Création is a private Venture Capital Company (RSC) which invests in innovative start-ups based in the Rhone-Alpes region. Rhône-Alpes Création mobilizes equity for young and high potential companies in the information technology, biotechnologies, and environment sectors.
For more information, visit: http://www.r-a-c.fr
Inserm Transfert Initiative is a seed-capital company that has raised €35.5 million in new funding in 2012. It focuses on providing seed capital for innovative young companies in the biomedical field. Inserm Transfert Initiative was created in 2005 through an equal partnership between four providers of finance to biotech startups: Inserm Transfert SA, CDC Entreprises, Natexis Venture Selection and Sofinnova Partners. Inserm Transfert Initiative supports biotech entrepreneurs in the early stages of their companies' development.
For more information, visit: www.it-initiative.fr